REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Damai Rx Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Damai Rx Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Export of pharmaceutical and medical goods, stores specialized in retail sale of pharmaceuticals, medical and orthopaedic goods, wholesale of pharmaceutical and medical goods.

Headquarters
No. 100A,, Jalan Alor Setar,, Guar Chempedak
Gurun; Kedah; Postal Code: 08800

Contact Details: Purchase the Damai Rx Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Damai Rx Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Damai Rx Sdn. Bhd. report to view the information.
Incorporation Date:
August 28, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Damai Rx Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
7.31%▲
Total operating revenue
7.31%▲
Operating profit (EBIT)
-41.97%▼
EBITDA
-33.14%▼
Net Profit (Loss) for the Period
-41.6%▼
Total assets
39.45%▲
Total equity
57.58%▲
Operating Profit Margin (ROS)
-2.5%▼
Net Profit Margin
-2.05%▼
Return on Equity (ROE)
-34.19%▼
Quick Ratio
0.24%▲
Cash Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo